India’s participation in global clinical trials has nearly quintupled between 2001 and 2005, as investment in the country by large international and domestic pharmaceutical companies, small and medium-sized Western biotechs and the National Institutes of Health (NIH) has grown as well. The clinical research outsourcing market in India grew to $70.5 million last year and will continue to climb.
India’s business and regulatory climates have undergone dramatic change in the past 18 months through passage of a patent bill, regulations updated to harmonize with U.S. and international standards, and plans for a more FDA-like regulatory body. In CenterWatch’s July issue of The CenterWatch Monthly, we explore these issues, challenges and trends within India’s burgeoning clincical trials market landscape.
-To read this article, or any other CenterWatch stories, please click here.